Research and Clinical Trials

LEMTRADA Infusion Vital Signs Study - OBS14379
Brief Description  
The research study will be conducted in adult subjects with relapsing forms of multiple sclerosis for which the decision to prescribe LEMTRADA has been made. The purpose of study is to further characterize the safety profile of LEMTRADA by systematic observation of vital signs during and shortly after LEMTRADA infusions of the first treatment course. Patient participation will last for approximately 2 to 7 week.
Who may be Eligible  
Adults patients diagnosed with relapsing multiple sclerosis who are planning treatment with LEMTRADA.
Start Date  
IRB Number  
Principal Investigator  
Graves, Donna
Contact Name  

For More Information, Contact  Joyce  , Pitner
Phone:  (704) 446-1349  Fax:  (704) 446-1915  
Address:Neurosciences Institute, Neurology-Charlotte 1010 Edgehill Road North Charlotte, NC 28207